エトポシドトニリベート製剤

Title:

エトポシドトニリベート製剤

Document Type and Number:

Japanese Patent JP2023539154

Kind Code:

A

Abstract:

エトポシドトニリベートと、ポリソルベートと、エタノールとを含む液体医薬製剤。上記液体医薬製剤を希釈することを含む、輸液の調製方法。癌の治療を必要とする患者における、癌の治療に使用するための上記組成物又は溶液。【選択図】なし

More Like This:

JP7168448	Compositions containing activated stem cells for infected wounds
WO/2018/096009	COMPOSITION COMPRISING AVERMECTIN COMPOUNDS WITHOUT GELLING AGENTS
WO/2004/075844	FORMULATION FOR USE IN THE PREVENTION AND TREATMENT OF CARBOHYDRATE INDUCED DISEASES AND CONDITIONS

Inventors:

Goody, David
Montes Vasquez, Anna
Martinez Rubio, Javier
thoma, rudy

Application Number:

JP2023512354A

Publication Date:

September 13, 2023

Filing Date:

August 19, 2021

Export Citation:

Assignee:

Selact Pharma GMBH

International Classes:

A61K31/7048; A61K9/08; A61K47/02; A61K47/10; A61K47/26; A61P1/16; A61P35/00; A61P35/04; A61P43/00

Attorney, Agent or Firm:

Takashi Shoji
Yuriko Sukenobu
Takuya Osugi
Akira Shoji
Takuyuki Oshima
Ayaka Nakajima

Previous Patent: Spunbond nonwoven fabric containing no residual harmful substances and having improved opening quali...

Next Patent: Systems and methods for producing silk fibroin solutions and powders containing silk fibroin